Lansoprazolo Sun Pharma

Lansoprazole, the active ingredient in Lansoprazolo Sun Pharma, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑esophageal reflux disease, peptic ulcer disease and related disorders.

GNH USA supplies Lansoprazolo Sun Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole acts on the gastric acid secretion pathway and is indicated for several gastrointestinal conditions. - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and acid regurgitation by lowering stomach acidity. - Erosive esophagitis: promotes healing of inflamed esophageal tissue caused by acid exposure. - Peptic ulcer disease: supports ulcer healing and prevents recurrence by suppressing acid. - Helicobacter pylori eradication: used in combination therapy to improve bacterial clearance. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors.

Adverse reactions may occur with lansoprazole therapy.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually transient. - Nausea or abdominal discomfort. - Flatulence: excess gas. - Constipation: occasional. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: hepatitis signs. - Interstitial nephritis: kidney inflammation.

Before initiating therapy, consider the following safety measures. - Assess renal function: adjust use if severe impairment is present. - Evaluate hepatic status: use cautiously in liver disease. - Review concomitant medications: avoid drugs that require gastric acidity for absorption. - Monitor long‑term users: watch for bone density loss and electrolyte disturbances. - Pregnancy and lactation: prescribe only if benefits outweigh potential risks. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Lansoprazole may alter the effectiveness of several co‑administered medicines.

Major Interactions (Avoid): - Antiretroviral protease inhibitors (e.g., atazanavir): reduced plasma levels. - Antifungal agents (e.g., ketoconazole, itraconazole): decreased absorption. - Clopidogrel: diminished antiplatelet activity.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation. - Methotrexate (high dose): possible accumulation, check serum levels. - Digoxin: slight increase in concentration, observe for toxicity. - Diazepam: enhanced sedation, adjust dose if needed.